Disease in a Dish: New Tools for Understanding Cellular Systems 

Rockland and The Scientist brought together a panel of experts to discuss emerging technologies for disease modeling in regenerative medicine and stem cell therapy.
Cell-based model systems are powerful tools for studying signaling pathways, deciphering disease mechanisms, and predicting drug activities. Advances in stem cell technology provide new opportunities for in vitro modeling and screening in a physiologically relevant environment that is consistent and replicable.
With speakers, Dr. Doo Yeon Kim, Assistant Professor of Neurology at Harvard Medical School and Dr. Jason Spence, Assistant Professor at the University of Michigan.
Established in 1962, Rockland Immunochemicals Inc. is a global biotechnology company manufacturing leading edge research tools for basic, applied and clinical research in functional genomics, gene therapy and drug discovery markets. Rockland is a privately held company which operates a manufacturing facility with antibody and protein production capabilities located near Philadelphia, Pennsylvania, USA. Global markets are supported through a highly specialized network of key distributors. Our laboratories consist of over 60,000 square feet, producing antibodies and antibody-based tools that are used to help define mechanisms underlying cell function and disease.